-
Je něco špatně v tomto záznamu ?
Renal cell carcinoma: Review of etiology, pathophysiology and risk factors
N. Petejova, A. Martinek,
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2001
Free Medical Journals
od 1998
Medline Complete (EBSCOhost)
od 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
od 2001
PubMed
26558360
DOI
10.5507/bp.2015.050
Knihovny.cz E-zdroje
- MeSH
- genetická predispozice k nemoci genetika MeSH
- karcinogeneze MeSH
- karcinom z renálních buněk diagnóza etiologie terapie MeSH
- lidé MeSH
- metastázy nádorů MeSH
- nádory ledvin diagnóza etiologie terapie MeSH
- radiační expozice škodlivé účinky MeSH
- rizikové faktory MeSH
- sloučeniny uranu škodlivé účinky MeSH
- staging nádorů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND AND AIMS: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm. METHODS: A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015. RESULTS AND CONCLUSIONS: Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.
Department of Clinical Studies Faculty of Medicine University of Ostrava Czech Republic
Department of Internal Medicine University Hospital Ostrava Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17012983
- 003
- CZ-PrNML
- 005
- 20170517081919.0
- 007
- ta
- 008
- 170413s2016 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2015.050 $2 doi
- 035 __
- $a (PubMed)26558360
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Petejová, Naděžda $u Department of Internal Medicine, University Hospital Ostrava, Czech Republic; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Czech Republic $7 xx0143726
- 245 10
- $a Renal cell carcinoma: Review of etiology, pathophysiology and risk factors / $c N. Petejova, A. Martinek,
- 520 9_
- $a BACKGROUND AND AIMS: The global incidence of renal cell cancer is increasing annually and the causes are multifactorial. Early diagnosis and successful urological procedures with partial or total nephrectomy can be life-saving. However, only up to 10% of RCC patients present with characteristic clinical symptoms. Over 60% are detected incidentally in routine ultrasound examination. The question of screening and preventive measures greatly depends on the cause of the tumor development. For the latter reason, this review focuses on etiology, pathophysiology and risk factors for renal neoplasm. METHODS: A literature search using the databases Medscape, Pubmed, UpToDate and EBSCO from 1945 to 2015. RESULTS AND CONCLUSIONS: Genetic predisposition/hereditary disorders, obesity, smoking, various nephrotoxic industrial chemicals, drugs and natural/manmade radioactivity all contribute and enviromental risks are a serious concern in terms of prevention and the need to screen populations at risk. Apropos treatment, current oncological research is directed to blocking cancer cell division and inhibiting angiogenesis based on a knowledge of molecular pathways.
- 650 _2
- $a karcinogeneze $7 D063646
- 650 _2
- $a karcinom z renálních buněk $x diagnóza $x etiologie $x terapie $7 D002292
- 650 _2
- $a genetická predispozice k nemoci $x genetika $7 D020022
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nádory ledvin $x diagnóza $x etiologie $x terapie $7 D007680
- 650 _2
- $a metastázy nádorů $7 D009362
- 650 _2
- $a staging nádorů $7 D009367
- 650 _2
- $a radiační expozice $x škodlivé účinky $7 D000069079
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sloučeniny uranu $x škodlivé účinky $7 D017974
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Martínek, Arnošt, $u Department of Internal Medicine, University Hospital Ostrava, Czech Republic; Department of Clinical Studies, Faculty of Medicine, University of Ostrava, Czech Republic $d 1952- $7 nlk20020123459
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Republic $x 1213-8118 $g Roč. 160, č. 2 (2016), s. 183-194
- 910 __
- $a ABA008 $b A 1502 $c 958 $y 4 $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20170425134608 $b ABA008
- 999 __
- $a ok $b bmc $g 1205379 $s 973756
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 160 $c 2 $d 183-194 $e 20151103 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20170413